November 3, 2025 November 3, 2025Categories EditorialsBeating the odds: Steven Merlin’s journey through pancreatic cancer and clinical trialsAn inspiring interview with a 13-year survivor of stage 4 pancreas cancer
November 3, 2025 November 3, 2025Categories EditorialsWhat a difference patients make: Honoring the impact of cancer clinical trial participantsECOG-ACRIN’s Trial Results Summaries Project aims to inform participants of study findings and express gratitude for their contributions to cancer research
November 3, 2025 November 3, 2025Categories New TrialsNow Enrolling: The EAA241 research study is exploring a new treatment approach for patients with newly diagnosed myeloma and kidney failureThis clinical trial aims to improve results with a set of medicines that will treat myeloma and reverse kidney failure at the same time
November 3, 2025 November 3, 2025Categories Ongoing TrialsOngoing Trials: A closer look at ECOG-ACRIN’s clinical trials for patients with pancreatic conditionsFor Pancreatic Cancer Awareness Month, we highlight two actively recruiting clinical trials for patients with pancreatic conditions
November 3, 2025 November 3, 2025Categories Trial ResultsTrial Results: ECOG-ACRIN research round-up – Fall 2025The latest discoveries from breast, leukemia, lung, nose/sinus, skin, and throat cancer clinical trials